General Information of the Protein
Protein ID
PT02571
Protein Name
Caspase-9
Secondarily
Protein Name
Apoptotic protease Mch-6
Apoptotic protease-activating factor 3
ICE-like apoptotic protease 6
Gene Name
CASP9
Secondarily
Gene Name
MCH6
Sequence
MDEADRRLLRRCRLRLVEELQVDQLWDALLSRELFRPHMIEDIQRAGSGSRRDQARQLIIDLETRGSQALPLFISCLEDTGQDMLASFLRTNRQAAKLSKPTLENLTPVVLRPEIRKPEVLRPETPRPVDIGSGGFGDVGALESLRGNADLAYILSMEPCGHCLIINNVNFCRESGLRTRTGSNIDCEKLRRRFSSLHFMVEVKGDLTAKKMVLALLELAQQDHGALDCCVVVILSHGCQASHLQFPGAVYGTDGCPVSVEKIVNIFNGTSCPSLGGKPKLFFIQACGGEQKDHGFEVASTSPEDESPGSNPEPDATPFQEGLRTFDQLDAISSLPTPSDIFVSYSTFPGFVSWRDPKSGSWYVETLDDIFEQWAHSEDLQSLLLRVANAVSVKGIYKQMPGCFNFLRKKLFFKTS
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Protease
>
Cysteine protease
>
Cysteine protease CD clan
>
Cysteine protease C14 family
Function
Involved in the activation cascade of caspases responsible for apoptosis execution. Binding of caspase-9 to Apaf-1 leads to activation of the protease which then cleaves and activates effector caspases caspase-3 (CASP3) or caspase-7 (CASP7). Promotes DNA damage-induced apoptosis in a ABL1/c-Abl-dependent manner. Proteolytically cleaves poly(ADP-ribose) polymerase (PARP).
    Show/Hide
Uniprot ID
Primary ID:
P55211

Secondarily ID:
B4E1A3
O95348
Q53Y70
Q5JRU9
Q5UGI1
Q92852
Q9BQ62
Q9UEQ3
Q9UIJ8
    Show/Hide
Ensembl ID
ENSG00000132906
HGNC ID
HGNC:1511
Clinical Information about the Protein
Target 1 ( Caspase-9 (CASP9) )
Target Type Clinical trial Target
Disease 1 Target-related Disease  1
1 Cystic fibrosis [ICD-11: CA25]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 isatin sulfonamide 34 Clinical trial
Cystic fibrosis